Fierce Pharma Asia—Legend CEO’s cell therapy ambitions; Indian pharmas’ awkward position; new Hutchmed CEO aliu Fri, 03/11/2022 – […]

BeiGene, Hutchmed, Zai Lab tagged for potential US delisting under SEC audit rules, with more Chinese biotechs likely […]

Amid inflation spike, execs at J&J, Bayer, GSK and more talk higher costs—and what it means for profits […]

Skoltech researchers and their colleagues from HSE University and York University have presented an extensive dataset of indices […]

Calculating a person’s risk of developing prostate cancer using results from two blood markers would improve the accuracy […]

Listen“Listen to the patient; he is telling you the diagnosis.” I should be surprised if this aphorism has […]

93% of people suspected by GPs to have cancer should be seen by a specialist within two weeks […]

The antiviral therapies remdesivir, molnupiravir, and the active ingredient in Pfizer’s Paxlovid pill (nirmatrelvir), remain effective in laboratory […]

If truth is the first casualty of war, the second is health and wellbeing. BMJ condemns Russia’s war […]

Certain areas in the UK have been experiencing a significant increase in COVID-19 cases in recent days